EMEA-002168-PIP01-17-M01

Key facts

Active substance
Onasemnogenum abeparvovecum
Therapeutic area
Neurology
Decision number
P/0162/2019
PIP number
EMEA-002168-PIP01-17-M01
Pharmaceutical form(s)
Solution for injection/infusion
Condition(s) / indication(s)
Treatment of spinal muscular atrophy
Route(s) of administration
  • Intravenous use
  • Intrathecal use
Contact for public enquiries
AveXis Netherlands B.V.

E-mail: medInfo@avexis.com
Tel. +1 8475728280

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating